SEER Share Price Performance
US$1.82
-0.50 (-21.55%)
39.3% undervalued intrinsic discount
US$3.00
Fair Value
Price US$1.82
AnalystConsensusTarget US$3.00
Fair ValueUS$3.29
Share Pricen/a
Seer, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
SEER Community Narratives
AN
Fair Value US$3.29 44.7% undervalued intrinsic discount
Proteograph Product Suite And Thermo Fisher Partnership Will Open Markets
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Proteograph Product Suite And Thermo Fisher Partnership Will Open Markets
Key Takeaways Strategic investments in commercial infrastructure and leadership aim to support revenue growth through increased productivity and sales effectiveness. Expanding partnerships and product innovation target enhanced adoption and customer value, potentially boosting sales and overall gross margins.Read more
16
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$3.29
44.7% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
32.74% p.a.
Profit Margin
12.89%
Future PE
41.54x
Price in 2028
US$3.69
Trending Discussion
Recently Updated Narratives
AN
Proteograph Product Suite And Thermo Fisher Partnership Will Open Markets
Fair Value: US$3.29 44.7% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Seer, Inc. Key Details
About SEER
- Founded
- 2017
- Employees
- 134
- CEO
- WebsiteView website
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
